Federal Register Notice: FDA is making available the report of its Task Force on Consumer Health Information for Better Nutrition and two final guidance documents entitled Guidance for Industry and FDA: Interim Evidence-Based Ranking System for Scientific Data and Guidance for Industry and FDA: Interim Procedures for Health Claims in the Labeling of Conventional Human Food and Human Dietary Supplements. These documents further update the agency's approach on how it intends to implement the Court of Appeals decision in Pearson v. Shalala (In this case the plaintiffs challenged FDA's general health claims regulations for dietary supplements and FDA's decision not to authorize health claims for four specific substance/disease relationships. The district court ruled for FDA, but the U.S. Court of Appeals for the DC Circuit reversed the lower court's decision holding that the first amendment does not permit FDA to reject health claims that the agency determines to be potentially misleading unless the agency also reasonably determines that no disclaimer would eliminate the potential deception.) To view this notice, click here.